CD8A and neoplasm: VPA/HPTA Reinforces the Anti-Tumor Effect of Radiotherapy by Activating CD8+ T Cell-Dependent Anti-Tumor Response and Inducing Vascular Normalization In Vivo at the Early Stage of the Treatment